Art. 90 Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…

In forcesince 26 Jan 2007cited 5×

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

By way of derogation from the first paragraph, Titles I, II, III and V shall apply from 20 November 2005 and point 3, fifth and sixth indent of the Annex shall apply from 20 May 2008.

  • Judgment of the General Court (Second Chamber) of 15 September 2015. Novartis Europharm Ltd v European Commission.Decision

    It should be noted, first, that, under Article 6(1) of Directive 2001/83, as amended, no medicinal product may be placed on the market of a Member State unless a marketing authorisation has been issued by the competent authorities of that …

    15 Sep 2015 · 62012TJ0472

  • Arrêt du Tribunal (deuxième chambre) du 15 septembre 2015. Novartis Europharm Ltd contre Commission européenne.Decision

    … by Regulation No 2309/93, which was applicable when marketing authorisation was granted for Aclasta pursuant to Article 90 of Regulation No 726/2004 (see paragraphs 5 and 8 above).

    15 Sep 2015 · 62013TJ0067

  • Judgment of the General Court (Fifth Chamber) of 9 September 2010. CSL Behring GmbH v European Commission and European Medicines Agency (EMADecision

    Член 90 от Регламент № 726/2004 гласи следното: „Настоящият регламент влиза в сила на двадесетия ден след публикуването му в Официален …

    9 Sep 2010 · 62007TJ0264

  • Opinion of Advocate General Szpunar delivered on 3 March 2015. Abcur AB v Apoteket Farmaci AB and Apoteket AB.Decision

    … членове 88 и 90 от Регламент № 726/2004.], попада в обхвата на някое от изключенията по член 3, точка 1 или член 3, точка 2 от Директива 2001/83, и …

    3 Mar 2015 · 62013CC0544

  • Judgment of the Court (Fourth Chamber) of 22 December 2010. European Commission v Republic of Poland.Decisionrelated

    22 Dec 2010 · 62008CJ0385